CTSA Program Funding Information

The CTSA Program provides critical resources and support needed to strengthen the entire spectrum of our nation’s clinical and translational research enterprise. CTSA Program hubs provide core resources, essential mentoring and training, and opportunities to develop innovative approaches and technologies designed to re-engineer existing capabilities. Program support also fosters collaborations to improve the quality, safety, efficiency and speed of clinical and translational research.

Funded Activities Under the CTSA Program

View a table of funded activities (PDF, 139KB) under the CTSA Program.

Current Funding Announcements

NCATS has released the following funding opportunity announcements for CTSA Program hub awards, Trial Innovation Centers, Recruitment Innovation Centers and Collaborative Innovation Awards.

Clinical and Translational Science Awards

  • NOT-TR-20-029: Notice of Special Interest (NOSI): New Administrative Supplement Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Heath Need
  • NOT-TR-20-019: Notice of Information: Change in NCATS Prior Approval Process for New CTSA Program Pilot Projects that Involve Human Subjects Research
  • NOT-TR-20-014: Notice of Special Interest: Clinical and Translational Science Award (CTSA) Program Administrative Supplements
  • NOT-TR-20-007: Notice of Special Interest: Research through NCATS’ Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Awards (U01 and R21)
  • NOT-TR-19-015: Notice of Information: NCATS Clinical and Translational Science Awards (CTSA) Programs Interest in Improving Rural Health Outcomes and Eliminating Health Disparities
  • PAR-18-940: Clinical and Translational Science Award (U54 Clinical Trial Optional)
    • NOT-TR-20-036: Notice of Change to Key Dates for PAR-18-940 Clinical and Translational Science Award (U54 Clinical Trial Optional)
    • NOT-TR-19-014: Notice of Change to PAR-18-940 Clinical and Translational Science Award (U54 Clinical Trial Optional)
      • NOT-TR-19-026: Notice of Change to NOT-TR-19-014: Notice of Change to PAR-18-940 Clinical and Translational Science Award (U54 Clinical Trial Optional)
    • NOT-TR-19-013: Notice of Change to PAR-18-940 Clinical and Translational Science Award (U54 Clinical Trial Optional)
    • NOT-TR-19-010: Notice of Change to PAR-18-940 Clinical and Translational Science Award (U54 Clinical Trial Optional)
    • CTSA Program PAR-18-940 Application Information

Collaborative Innovation Awards

  • PAR-19-099: Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award (U01 Clinical Trial Optional)
    • NOT-TR-20-004: Notice of Change to Award Budget and Removal of Prior Approval Requirement for PAR-19-099, Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award (U01 Clinical Trial Optional)
    • NOT-TR-19-023: Notice of Change to PAR-19-099 Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award (U01 Clinical Trial Optional)
    • NOT-TR-19-016: Notice of Change to FOA PAR-19-099: Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award (U01 Clinical Trial Optional)
  • PAR-19-100: Limited Competition: Clinical and Translational Science Award (CTSA) Program: Exploratory Collaborative Innovation Awards (R21 Clinical Trial Optional)
    • NOT-TR-19-024: Notice of Change to PAR-19-100 Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award (R21 Clinical Trial Optional)
    • NOT-TR-19-017Notice of Change to FOA PAR-19-100: Limited Competition: Clinical and Translational Science Award (CTSA) Program: Exploratory Collaborative Innovation Awards (R21 Clinical Trial Optional)
  • Collaborating, Implementing and Dissemination Innovations in Clinical and Translational Science Research – Application Information

Competitive Revision Awards

Administrative Supplements

  • NOT-TR-20-028: Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs
  • NOT-AT-20-010: Notice of Special Interest: NCCIH Administrative Supplements to NCATS CTSA Programs for Scholars Pursuing Complementary Health Research Career Development
  • PA-20-222: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
  • PA-18-592: Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed)
  • PA-18-591: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
    • NOT-OD-20-024: Notice of Special Interest (NOSI): Availability of Administrative Supplements for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down Syndrome) Project
    • NOT-HL-19-724: Notice of Special Interest (NOSI): Availability of Administrative and Revision Supplements to Expand Vaping Research and Understand EVALI

Conference Grants

View all of NCATS’ current funding opportunities.

Expired Funding Announcements

Visit the expired CTSA Program funding announcements page to learn more about past CTSA Program funding opportunities.